Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q85578739 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010855.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q85578739 | ||
024 | ‡a 0000-0003-4612-3236 ‡2 orcid | ||
024 | ‡a 55626148800 ‡2 scopus | ||
035 | ‡a (OCoLC)Q85578739 | ||
100 | 0 | ‡a Marcos Avila-Rodriguez ‡c researcher ‡9 en | |
400 | 0 | ‡a Marcos Avila-Rodriguez ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions. | ||
670 | ‡a Author's Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia. | ||
670 | ‡a Author's Application of Acyzol in the Context of Zinc Deficiency and Perspectives. | ||
670 | ‡a Author's Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome. | ||
670 | ‡a Author's Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status | ||
670 | ‡a Author's Copper and Neurotoxicity in Autism Spectrum Disorder | ||
670 | ‡a Author's Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor | ||
670 | ‡a Author's Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease? | ||
670 | ‡a Author's Medicinal plants as protective strategies against Parkinson's Disease. | ||
670 | ‡a Author's Microglial dependent protective effects of neuroactive steroids. | ||
670 | ‡a Author's Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer Disease | ||
670 | ‡a Author's Nanotechnology for Alzheimer Disease. | ||
670 | ‡a Author's Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review | ||
670 | ‡a Author's Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system. | ||
670 | ‡a Author's Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder. | ||
670 | ‡a Author's Protection by Neuroglobin Expression in Brain Pathologies | ||
670 | ‡a Author's Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics | ||
670 | ‡a Author's Sleep Disorders Associated With Alzheimer's Disease: A Perspective. | ||
670 | ‡a Author's Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression | ||
670 | ‡a Author's Tibolone protects T98G cells from glucose deprivation. | ||
670 | ‡a Author's Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta. | ||
909 | ‡a (orcid) 0000000346123236 ‡9 1 | ||
909 | ‡a (scopus) 55626148800 ‡9 1 | ||
919 | ‡a neurophysiologyandpsychopathologyunderlying PTSD andrecentinsightsintothe PTSD therapiesacomprehensivereview ‡A Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review ‡9 1 | ||
919 | ‡a neuroprotectiveeffectsofthecatalyticsubunitoftelomeraseapotentialtherapeutictargetinthecentralnervoussystem ‡A Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system. ‡9 1 | ||
919 | ‡a advancesinmedicinalplantswitheffectsonanxietybehaviorassociatedtomentalandhealthconditions ‡A Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions. ‡9 1 | ||
919 | ‡a alterationsinglucosemetabolismoncognitionapossiblelinkbetweendiabetesanddementia ‡A Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia. ‡9 1 | ||
919 | ‡a applicationofacyzolinthecontextofzincdeficiencyandperspectives ‡A Application of Acyzol in the Context of Zinc Deficiency and Perspectives. ‡9 1 | ||
919 | ‡a approachesforthedevelopmentofdrugsfortreatmentofobesityandmetabolicsyndrome ‡A Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome. ‡9 1 | ||
919 | ‡a canmirnasbeconsideredasdiagnosticandtherapeuticmoleculesinischemicstrokepathogenesiscurrentstatus ‡A Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status ‡9 1 | ||
919 | ‡a copperandneurotoxicityinautismspectrumdisorder ‡A Copper and Neurotoxicity in Autism Spectrum Disorder ‡9 1 | ||
919 | ‡a growthfactorsandastrocytesmetabolismpossiblerolesforplateletderivedgrowthfactor ‡A Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor ‡9 1 | ||
919 | ‡a tibolonereducesoxidativedamageandinflammationinmicrogliastimulatedwithpalmiticacidthroughmechanismsinvolvingestrogenreceptorbeta ‡A Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta. ‡9 1 | ||
919 | ‡a tiboloneprotectst98gcellsfromglucosedeprivation ‡A Tibolone protects T98G cells from glucose deprivation. ‡9 1 | ||
919 | ‡a isvegfakeytargetofcotinineandotherpotentialtherapiesagainstalzheimerdisease ‡A Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease? ‡9 1 | ||
919 | ‡a tiboloneprotectsastrocyticcellsfromglucosedeprivationthroughamechanisminvolvingestrogenreceptorbetaandtheupregulationofneuroglobinexpression ‡A Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression ‡9 1 | ||
919 | ‡a medicinalplantsasprotectivestrategiesagainstparkinsonsdisease ‡A Medicinal plants as protective strategies against Parkinson's Disease. ‡9 1 | ||
919 | ‡a sleepdisordersassociatedwithalzheimersdiseaseaperspective ‡A Sleep Disorders Associated With Alzheimer's Disease: A Perspective. ‡9 1 | ||
919 | ‡a microglialdependentprotectiveeffectsofneuroactivesteroids ‡A Microglial dependent protective effects of neuroactive steroids. ‡9 1 | ||
919 | ‡a sexdifferencesinparkinsonsdiseasefeaturesonclinicalsymptomstreatmentoutcomesexualhormonesandgenetics ‡A Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics ‡9 1 | ||
919 | ‡a mitochondrialpermeabilitytransitionporeasasuitabletargetforneuroprotectiveagentsagainstalzheimerdisease ‡A Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer Disease ‡9 1 | ||
919 | ‡a protectionbyneuroglobinexpressioninbrainpathologies ‡A Protection by Neuroglobin Expression in Brain Pathologies ‡9 1 | ||
919 | ‡a nanotechnologyforalzheimerdisease ‡A Nanotechnology for Alzheimer Disease. ‡9 1 | ||
919 | ‡a nicotinederivedcompoundsastherapeutictoolsagainstposttraumaticstressdisorder ‡A Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder. ‡9 1 | ||
996 | ‡2 ISNI|0000000396187481 | ||
996 | ‡2 DNB|1057068004 | ||
996 | ‡2 LC|n 85057857 | ||
996 | ‡2 LC|n 2010026176 | ||
996 | ‡2 PTBNP|1591076 | ||
996 | ‡2 LC|no2007146083 | ||
996 | ‡2 NII|DA16082274 | ||
996 | ‡2 DNB|131877844 | ||
996 | ‡2 LC|nb2019022234 | ||
996 | ‡2 LC|n 78098235 | ||
996 | ‡2 J9U|987007361192205171 | ||
996 | ‡2 LC|no2011091315 | ||
996 | ‡2 BNC|981058616864906706 | ||
996 | ‡2 DNB|1057452173 | ||
996 | ‡2 BNE|XX1082751 | ||
996 | ‡2 LC|ns2016000698 | ||
996 | ‡2 DNB|108193882X | ||
996 | ‡2 BNC|981060918133706706 | ||
996 | ‡2 LC|no2011080900 | ||
996 | ‡2 ISNI|0000000497186250 | ||
996 | ‡2 DNB|107495999X | ||
996 | ‡2 LC|ns2019000075 | ||
996 | ‡2 LC|no2019073416 | ||
996 | ‡2 LC|no2008128081 | ||
996 | ‡2 BNE|XX842274 | ||
996 | ‡2 DNB|1061304213 | ||
996 | ‡2 DNB|1057592870 | ||
996 | ‡2 BNE|XX1554480 | ||
996 | ‡2 LC|no 00030536 | ||
996 | ‡2 BNE|XX1652163 | ||
996 | ‡2 SUDOC|07470446X | ||
996 | ‡2 BIBSYS|90688593 | ||
996 | ‡2 ISNI|0000000038121466 | ||
996 | ‡2 ISNI|0000000060533280 | ||
996 | ‡2 DNB|141068892 | ||
996 | ‡2 BNCHL|10000000000000000803120 | ||
996 | ‡2 LC|ns2013002739 | ||
996 | ‡2 DNB|101532665X | ||
996 | ‡2 SUDOC|085871893 | ||
996 | ‡2 SUDOC|161693040 | ||
996 | ‡2 LC|no2007064497 | ||
996 | ‡2 SUDOC|223551996 | ||
996 | ‡2 PLWABN|9810629392405606 | ||
996 | ‡2 BNE|XX5398172 | ||
996 | ‡2 SUDOC|226958809 | ||
996 | ‡2 BNC|981061046571406706 | ||
996 | ‡2 BLBNB|000336088 | ||
996 | ‡2 BNCHL|10000000000000000271825 | ||
996 | ‡2 BNCHL|10000000000000000839160 | ||
996 | ‡2 LC|no2022119029 | ||
996 | ‡2 BNF|12263448 | ||
996 | ‡2 LC|n 2022024365 | ||
996 | ‡2 ISNI|0000000119467872 | ||
996 | ‡2 NLA|000035238299 | ||
996 | ‡2 LC|n 85225155 | ||
996 | ‡2 LC|ns2018000453 | ||
996 | ‡2 RERO|A018919324 | ||
996 | ‡2 J9U|987007335616005171 | ||
996 | ‡2 BNF|15719522 | ||
996 | ‡2 ISNI|0000000400555479 | ||
996 | ‡2 SUDOC|116316292 | ||
996 | ‡2 ISNI|0000000432059955 | ||
996 | ‡2 LC|no2016125641 | ||
996 | ‡2 LC|no2003115646 | ||
996 | ‡2 ISNI|0000000078733803 | ||
996 | ‡2 SUDOC|245410228 | ||
996 | ‡2 ISNI|0000000059242806 | ||
996 | ‡2 BNE|XX1630605 | ||
996 | ‡2 LC|no2006099962 | ||
996 | ‡2 ISNI|0000000051254685 | ||
996 | ‡2 ISNI|0000000108185538 | ||
996 | ‡2 SUDOC|256012717 | ||
996 | ‡2 LC|n 2008056890 | ||
996 | ‡2 CAOONL|ncf10323044 | ||
996 | ‡2 BNC|981058507650606706 | ||
996 | ‡2 LC|no 97031938 | ||
996 | ‡2 PTBNP|1466929 | ||
996 | ‡2 LC|no2020029734 | ||
996 | ‡2 SUDOC|117857734 | ||
996 | ‡2 BNE|XX1768164 | ||
996 | ‡2 NUKAT|n 99041890 | ||
996 | ‡2 NUKAT|n 2017075764 | ||
996 | ‡2 BNC|981060554271806706 | ||
996 | ‡2 ISNI|0000000078243935 | ||
996 | ‡2 BIBSYS|90905400 | ||
996 | ‡2 PLWABN|9814001217405606 | ||
996 | ‡2 B2Q|0001205354 | ||
996 | ‡2 ISNI|0000000029029780 | ||
996 | ‡2 BNE|XX5267530 | ||
996 | ‡2 BNE|XX5542221 | ||
996 | ‡2 ISNI|0000000078065446 | ||
996 | ‡2 NTA|344550680 | ||
996 | ‡2 LC|n 84104399 | ||
996 | ‡2 LC|n 98026541 | ||
996 | ‡2 NTA|298791234 | ||
996 | ‡2 BNC|981058611000706706 | ||
996 | ‡2 J9U|987007339973105171 | ||
996 | ‡2 CAOONL|ncf10177356 | ||
996 | ‡2 LC|no2021117063 | ||
996 | ‡2 LC|ns2023002636 | ||
996 | ‡2 DNB|170697541 | ||
996 | ‡2 BNE|XX5700754 | ||
996 | ‡2 LC|ns2024002920 | ||
996 | ‡2 BNC|981058525515806706 | ||
996 | ‡2 DNB|1163816590 | ||
996 | ‡2 BNCHL|10000000000000000126596 | ||
996 | ‡2 BNE|XX5118342 | ||
996 | ‡2 LC|n 2001087821 | ||
996 | ‡2 ISNI|0000000036299228 | ||
996 | ‡2 ISNI|0000000000986245 | ||
996 | ‡2 ISNI|0000000053683301 | ||
996 | ‡2 DNB|171708067 | ||
996 | ‡2 BNC|981058608765606706 | ||
996 | ‡2 LC|ns2014000190 | ||
996 | ‡2 ISNI|000000037186612X | ||
996 | ‡2 ISNI|000000040924620X | ||
996 | ‡2 PTBNP|1659907 | ||
996 | ‡2 ISNI|0000000051647948 | ||
996 | ‡2 BNCHL|10000000000000000101855 | ||
996 | ‡2 BNF|13558790 | ||
996 | ‡2 BNE|XX1150740 | ||
996 | ‡2 DNB|1064681697 | ||
996 | ‡2 ISNI|0000000454612854 | ||
996 | ‡2 CAOONL|ncf11039556 | ||
996 | ‡2 NSK|000605072 | ||
996 | ‡2 BNCHL|10000000000000000260720 | ||
996 | ‡2 PLWABN|9811511592105606 | ||
996 | ‡2 BNE|XX4917796 | ||
996 | ‡2 ISNI|0000000080826507 | ||
996 | ‡2 ISNI|0000000083649171 | ||
996 | ‡2 BNE|XX920176 | ||
996 | ‡2 PLWABN|9810558772205606 | ||
996 | ‡2 BNCHL|10000000000000000198547 | ||
996 | ‡2 ISNI|0000000060416076 | ||
996 | ‡2 NTA|310376327 | ||
996 | ‡2 RERO|A003754220 | ||
996 | ‡2 LC|ns2020000686 | ||
996 | ‡2 BNE|XX1780717 | ||
996 | ‡2 PLWABN|9810542155505606 | ||
996 | ‡2 ISNI|0000000060779758 | ||
996 | ‡2 SUDOC|11009767X | ||
996 | ‡2 LC|ns2012000847 | ||
996 | ‡2 BIBSYS|7030694 | ||
996 | ‡2 BNF|16146019 | ||
996 | ‡2 BNE|XX6140434 | ||
996 | ‡2 BNF|13171070 | ||
996 | ‡2 NTA|419255117 | ||
996 | ‡2 LC|no2011081835 | ||
996 | ‡2 SUDOC|074629654 | ||
996 | ‡2 ISNI|0000000031060015 | ||
996 | ‡2 LC|n 2003072735 | ||
996 | ‡2 BNCHL|10000000000000000245732 | ||
996 | ‡2 DNB|130826790 | ||
996 | ‡2 LC|ns2015001088 | ||
996 | ‡2 LC|no2018067548 | ||
996 | ‡2 BNE|XX1644107 | ||
996 | ‡2 ISNI|0000000038021967 | ||
996 | ‡2 LC|ns2019003628 | ||
996 | ‡2 BNE|XX6509118 | ||
996 | ‡2 DNB|1061538397 | ||
996 | ‡2 DNB|1192919912 | ||
996 | ‡2 SUDOC|031416128 | ||
996 | ‡2 LC|no2019115088 | ||
996 | ‡2 RERO|A003754217 | ||
996 | ‡2 SUDOC|187116970 | ||
996 | ‡2 BIBSYS|14028811 | ||
996 | ‡2 DNB|1018427058 | ||
996 | ‡2 LC|n 2004044454 | ||
996 | ‡2 ISNI|0000000418487646 | ||
996 | ‡2 ISNI|0000000050872609 | ||
996 | ‡2 ISNI|0000000120042206 | ||
996 | ‡2 DNB|131678639 | ||
996 | ‡2 LC|no2022137235 | ||
996 | ‡2 DNB|1057051322 | ||
996 | ‡2 ISNI|0000000078835834 | ||
996 | ‡2 SUDOC|104541806 | ||
996 | ‡2 LC|n 97033493 | ||
996 | ‡2 LC|no2024136409 | ||
996 | ‡2 DNB|136204627 | ||
996 | ‡2 LC|no2018025005 | ||
996 | ‡2 BIBSYS|1707990472561 | ||
996 | ‡2 NTA|304110655 | ||
996 | ‡2 ISNI|0000000432954968 | ||
996 | ‡2 DNB|1057271306 | ||
996 | ‡2 DNB|1057277746 | ||
996 | ‡2 NTA|11073470X | ||
996 | ‡2 ISNI|0000000075438542 | ||
996 | ‡2 LC|no2010200677 | ||
996 | ‡2 DNB|135267277 | ||
996 | ‡2 BLBNB|001500212 | ||
996 | ‡2 BNE|XX5424072 | ||
996 | ‡2 CAOONL|ncf10924331 | ||
996 | ‡2 SUDOC|052499685 | ||
996 | ‡2 LC|no2015148286 | ||
996 | ‡2 LC|no2008076882 | ||
996 | ‡2 ISNI|000000004277155X | ||
996 | ‡2 ISNI|0000000500593907 | ||
996 | ‡2 ISNI|0000000025879796 | ||
996 | ‡2 ISNI|000000006102404X | ||
996 | ‡2 ISNI|0000000059964577 | ||
996 | ‡2 ISNI|0000000073781865 | ||
996 | ‡2 DNB|140196501 | ||
996 | ‡2 ISNI|0000000032372395 | ||
996 | ‡2 ISNI|0000000451873709 | ||
996 | ‡2 LC|no2009007539 | ||
996 | ‡2 BNC|981061210707306706 | ||
996 | ‡2 NUKAT|n 2022128112 | ||
996 | ‡2 BNF|12441085 | ||
996 | ‡2 LC|n 86021430 | ||
996 | ‡2 BNE|XX5591989 | ||
996 | ‡2 LC|n 87111428 | ||
996 | ‡2 BNE|XX1542968 | ||
996 | ‡2 LC|n 81104768 | ||
996 | ‡2 LC|no2018172811 | ||
996 | ‡2 ISNI|0000000072176874 | ||
996 | ‡2 LC|no2017036630 | ||
996 | ‡2 LC|no2006075762 | ||
996 | ‡2 ISNI|0000000117567394 | ||
996 | ‡2 BNE|XX6174100 | ||
996 | ‡2 BNE|XX1093477 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |